236 related articles for article (PubMed ID: 9199965)
1. Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes.
Morrot A; Strickland DK; Higuchi Mde L; Reis M; Pedrosa R; Scharfstein J
Int Immunol; 1997 Jun; 9(6):825-34. PubMed ID: 9199965
[TBL] [Abstract][Full Text] [Related]
2. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase.
Arnholdt AC; Piuvezam MR; Russo DM; Lima AP; Pedrosa RC; Reed SG; Scharfstein J
J Immunol; 1993 Sep; 151(6):3171-9. PubMed ID: 7690795
[TBL] [Abstract][Full Text] [Related]
3. Parasite cysteine proteinase interactions with alpha 2-macroglobulin or kininogens: differential pathways modulating inflammation and innate immunity in infection by pathogenic trypanosomatids.
Scharfstein J
Immunobiology; 2006; 211(1-2):117-25. PubMed ID: 16446176
[TBL] [Abstract][Full Text] [Related]
4. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi: cruzipain and membrane-bound cysteine proteinase isoform(s) interacts with human alpha(2)-macroglobulin and pregnancy zone protein.
Ramos AM; Duschak VG; Gerez de Burgos NM; Barboza M; Remedi MS; Vides MA; Chiabrando GA
Exp Parasitol; 2002 Feb; 100(2):121-30. PubMed ID: 12054702
[TBL] [Abstract][Full Text] [Related]
6. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections.
Martinez J; Campetella O; Frasch AC; Cazzulo JJ
Infect Immun; 1991 Nov; 59(11):4275-7. PubMed ID: 1937786
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII).
Laderach D; Cerban F; Motran C; Vottero de Cima E; Gea S
Int J Parasitol; 1996 Nov; 26(11):1249-54. PubMed ID: 9024869
[TBL] [Abstract][Full Text] [Related]
8. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
[TBL] [Abstract][Full Text] [Related]
9. Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice.
Guiñazú N; Pellegrini A; Giordanengo L; Aoki MP; Rivarola HW; Cano R; Rodrigues MM; Gea S
Microbes Infect; 2004 Nov; 6(14):1250-8. PubMed ID: 15555530
[TBL] [Abstract][Full Text] [Related]
10. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite.
Giordanengo L; Guiñazú N; Stempin C; Fretes R; Cerbán F; Gea S
Eur J Immunol; 2002 Apr; 32(4):1003-11. PubMed ID: 11920566
[TBL] [Abstract][Full Text] [Related]
11. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients.
Fonseca SG; Moins-Teisserenc H; Clave E; Ianni B; Nunes VL; Mady C; Iwai LK; Sette A; Sidney J; Marin ML; Goldberg AC; Guilherme L; Charron D; Toubert A; Kalil J; Cunha-Neto E
Microbes Infect; 2005 Apr; 7(4):688-97. PubMed ID: 15848276
[TBL] [Abstract][Full Text] [Related]
12. [The proliferative response of T cells against cruzipain in chronic chagasic cardiopathy].
Pedrosa RC; Saad EA; Scharfstein J; Lima AM
Rev Soc Bras Med Trop; 1996; 29(4):331-9. PubMed ID: 8768581
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: immunological cross-reactivity of the major cysteinyl proteinase (cruzipain) with a parasite cytosol acidic antigen (FIV).
Cerban FM; Motran C; Laderach D; Gea S; Gruppi A; Vottero-Cima E
Acta Trop; 1994 Dec; 58(3-4):337-43. PubMed ID: 7709872
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases.
Serveau C; Lalmanach G; Hirata I; Scharfstein J; Juliano MA; Gauthier F
Eur J Biochem; 1999 Jan; 259(1-2):275-80. PubMed ID: 9914503
[TBL] [Abstract][Full Text] [Related]
15. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
Front Immunol; 2020; 11():1279. PubMed ID: 32695105
[TBL] [Abstract][Full Text] [Related]
16. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.
Lima AP; dos Reis FC; Serveau C; Lalmanach G; Juliano L; Ménard R; Vernet T; Thomas DY; Storer AC; Scharfstein J
Mol Biochem Parasitol; 2001 Apr; 114(1):41-52. PubMed ID: 11356512
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases.
Yong V; Schmitz V; Vannier-Santos MA; de Lima AP; Lalmanach G; Juliano L; Gauthier F; Scharfstein J
Mol Biochem Parasitol; 2000 Jun; 109(1):47-59. PubMed ID: 10924756
[TBL] [Abstract][Full Text] [Related]
18. Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection.
Cazorla SI; Frank FM; Becker PD; Arnaiz M; Mirkin GA; Corral RS; Guzmán CA; Malchiodi EL
J Infect Dis; 2010 Jul; 202(1):136-44. PubMed ID: 20497050
[TBL] [Abstract][Full Text] [Related]
19. Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review.
Duschak VG; Couto AS
Curr Med Chem; 2009; 16(24):3174-202. PubMed ID: 19689291
[TBL] [Abstract][Full Text] [Related]
20. Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor-related protein.
Warshawsky I; Bu G; Schwartz AL
J Biol Chem; 1993 Oct; 268(29):22046-54. PubMed ID: 7691821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
